Treatment with LYR-120 was associated with a statistically significant improvement over sham in the composite of 3 cardinal symptoms of CRS at week 24 in patients without nasal polyps. Topline results ...
Neoadjuvant chemotherapy prior to surgery and postoperative radiation therapy could improve organ preservation in patients with T3 and T4a nasal and paranasal sinus squamous cell carcinoma.
Introduction Diseases of the paranasal sinuses, nasal cavities, and those related to the skull base can be treated with nasal endoscopic surgery. Anatomical references are essential to safely perform ...
Treatment with LYR-210 did not result in a statistically significant improvement in the composite score of 3 cardinal symptoms of CRS compared with sham. Findings from a phase 3 trial evaluating ...
WATERTOWN, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory ...
-- Data from ENLIGHTEN I Pivotal Phase 3 Trial of LYR-210 in Chronic Rhinosinusitis (CRS) Anticipated Q2 2024 -- WATERTOWN, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: ...
A 49-year-old woman in Nevada developed foreign body (FB) sinusitis after amalgam restorative material moved from a tooth in her upper jaw into the paranasal sinuses. The case report was published ...
No one's thrilled to get sick, but there's something extra cruddy about a sinus infection. The pain, the pressure, the congestion, ugh! If you're dealing with these symptoms right now, you're probably ...
Study demonstrates statistically significant and clinically relevant improvements in 3 Cardinal Symptoms and SNOT-22 scores at 24 weeks Statistically significant improvements in efficacy were observed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results